[EN] TGONOVEL HDAC INHIBITORS AND THERAPEUTIC USE THEREOF [FR] NOUVEAUX INHIBITEURS DE HDAC ET LEUR UTILISATION THÉRAPEUTIQUE
摘要:
Described herein are novel compounds, compositions and methods for treatment of diseases including cancer using such compounds, compositions, and methods. The compounds include those of Formula (I):
[EN] PYRIMIDINE AND PYRAZINE HDAC1,2 INHIBITORS<br/>[FR] INHIBITEURS DE PYRIMIDINE ET DE PYRAZINE HDAC 1, 2
申请人:REGENACY PHARMACEUTICALS LLC
公开号:WO2020076951A1
公开(公告)日:2020-04-16
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.